Erratum to "PKC zeta controls DNA topoisomerase-dependent human caspase-2 pre-mRNA splicing" [FEBS Lett. 582 (2008) 372-378] (DOI:10.1016/j.febslet.2007.12.032);PKC zeta controls DNA topoisomerase-dependent human caspase-2 pre-mRNA splicing

FEBS Letters

Volumn 582, Issue 2, 2008, Pages 372-378

  Solier, Stéphanie ^a,b   De Cian, Marie Cécile ^d   Bettaieb, Ali ^a,c   Desoche, Lydie ^a   Solary, Eric ^a   Corcos, Laurent ^a,d  

^a INSERM   (France)

^b HÔPITAL DU BOCAGE   (France)

^c NONE

^d FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

Caspase 2; Cell cycle; mRNA splicing; PKC zeta; Topoisomerase

Indexed keywords

CASPASE 2; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; PROTEIN KINASE C ZETA;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXON; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING;

EID: 38049086171     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.01.012     Document Type: Erratum

References (44)

1. Caceres J.F., and Kornblihtt A.R. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18 (2002) 186-193
2. Modrek B., and Lee C. Genomic view of alternative splicing. Nat. Genet. 30 (2002) 13-19
3. Municio M.M., Lozano J., Sanchez P., Moscat J., and Diaz-Meco M.T. Identification of heterogenous ribonucleoprotein A1 as a novel substrate for protein kinase C zeta. J. Biol. Chem. 270 (1995) 15884-15891
4. Ngo J.C., Chakrabarti S., Ding J.H., Velasquez-Dones A., Nolen B., Aubol B.E., Aadams J.A., Fu X.D., and Ghosh G. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol. Cell 20 (2005) 77-89
5. Pilch B., Allemand E., Facompre M., Bailly C., Riou J.F., Soret J., and Tazi J. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 61 (2001) 6876-6884
6. Sanford J.R., and Bruzik J.P. Developmental regulation of SR protein phosphorylation and activity. Gene Dev. 13 (1999) 1513-1518
7. Jiang Z.H., and Wu J.Y. Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med. 220 (1999) 64-72
8. Wang L., Miura M., Bergeron L., Zhu H., and Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78 (1994) 739-750
9. Droin N., Rebe C., Bichat F., Hammann A., Bertrand R., and Solary E. Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization. Oncogene 20 (2001) 260-269
10. Logette E., Wotawa A., Solier S., Desoche L., Solary E., and Corcos L. The human caspase-2 gene: alternative promoters, pre-mRNA splicing and AUG usage direct isoform-specific expression. Oncogene 22 (2003) 935-946
11. Solier S., Logette E., Desoche L., Solary E., and Corcos L. Nonsense-mediated mRNA decay among human caspases: the caspase-2S putative protein is encoded by an extremely short-lived mRNA. Cell Death Differ. 12 (2005) 687-689
12. Solier S., Lansiaux A., Logette E., Wu J., Soret J., Tazi J., Bailly C., Desoche L., Solary E., and Corcos L. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. Mol. Cancer Res. 2 (2004) 53-61
13. Wotawa A., Solier S., Logette E., Solary E., and Corcos L. Differential influence of etoposide on two caspase-2 mRNA isoforms in leukemic cells. Cancer Lett. 185 (2002) 181-189
14. Borowiec J.A. The toposome: a new twist on topoisomerase II alpha. Cell Cycle 3 (2004) 627-628
15. Lee C.G., Hague L.K., Li H., and Donnelly R. Identification of toposome, a novel multisubunit complex containing topoisomerase II alpha. Cell Cycle 3 (2004) 638-647
16. Mellor H., and Parker P.J. The extended protein kinase C superfamily. Biochem. J. 332 Pt 2 (1998) 281-292
17. Etienne-Manneville S., and Hall A. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKC zeta. Cell 106 (2001) 489-498
18. Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal. 18 (2006) 276-284
19. Diaz-Meco M.T., Dominguez I., Sanz L., Dent P., Lozano J., Municio M.M., Berra E., Hay R.T., Sturgill T.W., and Moscat J. Zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro. EMBO J. 13 (1994) 2842-2848
20. Thanos D., and Maniatis T. NF-kappa B: a lesson in family values. Cell 80 (1995) 529-532
21. Mancini A., Koch A., Whetton A.D., and Tamura T. The M-CSF receptor substrate and interacting protein FMIP is governed in its subcellular localization by protein kinase C-mediated phosphorylation, and thereby potentiates M-CSF-mediated differentiation. Oncogene 23 (2004) 6581-6589
22. Filomenko R., Poirson-Bichat F., Billerey C., Belon J.P., Garrido C., Solary E., and Bettaieb A. Atypical protein kinase C zeta as a target for chemosensitization of tumor cells. Cancer Res. 62 (2002) 1815-1821
23. Barboule N., Lafon C., Chadebech P., Vidal S., and Valette A. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett. 444 (1999) 32-37
24. McCracken M.A., Miraglia L.J., McKay R.A., and Strobl J.S. Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. Mol. Cancer Ther. 2 (2003) 273-281
25. Way K.J., Chou E., and King G.L. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21 (2000) 181-187
26. Leroy I., de Thonel A., Laurent G., and Quillet-Mary A. Protein kinase C zeta associates with death inducing signaling complex and regulates Fas ligand-induced apoptosis. Cell Signal. 17 (2005) 1149-1157
27. Perfetti A., Oriente F., Iovino S., Alberobello A.T., Barbagallo A.P., Esposito I., Fiory F., Teperino R., Ungaro P., Miele C., Formisano P., and Beguinot F. Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteosomal degradation. J. Biol. Chem. 282 (2007) 8648-8657
28. Baier-Bitterlich G., Uberall F., Bauer B., Fresser F., Wachter H., Grunicke H., Utermann G., Altman A., and Baier G. Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol. Cell Biol. 16 (1996) 1842-1850
29. Jiang Z.H., Zhang W.J., Rao Y., and Wu J.Y. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc. Natl. Acad. Sci. USA 95 (1998) 9155-9160
30. Ding J.H., Zhong X.Y., Hagopian J.C., Cruz M.M., Ghosh G., Feramisco J., Adams J.A., and Fu X.D. Regulated cellular partitioning of SR protein-specific kinases in mammalian cells. Mol. Biol Cell. 17 (2006) 876-885
31. Rosenberger U., Lehmann I., Weise C., Franke P., Hucho F., and Buchner K. Identification of PSF as a protein kinase Calpha-binding protein in the cell nucleus. J. Cell Biochem. 86 (2002) 394-402
32. Zhu Y.Q., Lu Y., and Tan X.D. Monochloramine induces reorganization of nuclear speckles and phosphorylation of SRp30 in human colonic epithelial cells: role of protein kinase C. Am. J. Physiol. Cell Physiol. 285 (2003) C1294-C1303
33. Plo I., Hernandez H., Kohlhagen G., Lautier D., Pommier Y., and Laurent G. Overexpression of the atypical protein kinase C zeta reduces topoisomerase II catalytic activity, cleavable complexes formation, and drug-induced cytotoxicity in monocytic U937 leukemia cells. J. Biol. Chem. 277 (2002) 31407-31415
34. Hofland K., Petersen B.O., Falck J., Helin K., Jensen P.B., and Sehested M. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Clin. Cancer Res. 6 (2000) 1488-1497
35. de la Mata M., Alonso C.R., Kadener S., Fededa J.P., Blaustein M., Pelisch F., Cramer P., Bentley D., and Kornblihtt A.R. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell 12 (2003) 525-532
36. Batsche E., Yaniv M., and Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat. Struct. Mol. Biol. 13 (2006) 22-29
37. Kornblihtt A.R. Chromatin, transcript elongation and alternative splicing. Nat. Struct. Mol. Biol. 13 (2006) 5-7
38. Nogues G., Munoz M.J., and Kornblihtt A.R. Influence of polymerase II processivity on alternative splicing depends on splice site strength. J. Biol. Chem. 278 (2003) 52166-52171
39. Listerman I., Sapra A.K., and Neugebauer K.M. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat. Struct. Mol. Biol. 13 (2006) 815-822
40. Straub T., Grue P., Uhse A., Lisby M., Knudsen B.R., Tange T.O., Westergaard O., and Boege F. RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction. J. Biol. Chem. 273 (1998) 26261-26264
41. Andersen F.F., Tange T.O., Sinnathamby T., Olesen J.R., Andersen K.E., Westergaard O., Kjems J., and Knudsen B.R. The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation. J. Mol. Biol. 322 (2002) 677-686
42. Shin C., and Manley J.L. The SR protein SRp38 represses splicing in M phase cells. Cell 111 (2002) 407-417
43. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., and Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268 (1993) 9194-9197
44. Moscat J., Rennert P., and Diaz-Meco M.T. PKC zeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ. 13 (2006) 702-711